FindTrial
Sign In

Evaluation of IgE level on Tamak Swas

Diagnostic evaluation of Tamak Swas on the basis of IgE level - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/067568
Enrollment
60
Registered
2024-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Sponsors

Dr Smirti Priyanshu
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The age of patient should be between 20-60 years. The sign and symptom of the patients should be based on ayurvedic views.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women. Life threatening disorders.

Design outcomes

Primary

MeasureTime frame
Evaluation of tamaka swasa symptoms like ghurghurakam,swasakrichrata,anidra,ura parswa peeda, nishtyutante,aseeno labhate saukhyam on the basis of ige.Timepoint: 15 days—

Secondary

MeasureTime frame
Evaluation of additional symptomsTimepoint: 15 days—

Countries

India

Contacts

Public ContactDr Basant Kumar Thakur

Government Ayurvedic College & Hospital Patna

drbkthakur@rediffmail.com9430252475

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026